Shofu (7979) Fundamentals 2026 — P/E 15.7x, Revenue Analysis | SniperIQ
Shofu (7979) is a JP-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of ¥76.8B, trading at ¥2159.00 on the JPX. This SniperIQ fundamentals page covers Shofu's valuation (P/E 15.7x, P/B 1.6x), profitability (net margin 12.2%), revenue (¥40.0B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Shofu's market cap?
Shofu (7979) has a market capitalization of approximately ¥76.8B, trading at ¥2159.00 on the JPX. Market cap moves with the live share price.
What is Shofu's P/E ratio?
Shofu's trailing twelve-month P/E ratio is 15.7x, with a price-to-book (P/B) of 1.6x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Shofu?
Shofu runs a net profit margin of 12.2%, a gross margin of 59.4%, and an operating margin of 13.1%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Shofu generate?
Shofu reported revenue of ¥40.0B for fiscal year 2025, with net income of ¥4.9B and earnings per share (EPS) of 137.36. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Shofu pay a dividend?
Shofu offers a trailing dividend yield of about 2.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Shofu financially healthy?
Shofu carries a debt-to-equity ratio of 0.01x and a current ratio of 4.74x, with a market beta of 0.15. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Shofu a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Shofu (7979) the key facts are: market cap ¥76.8B, P/E 15.7x, revenue ¥40.0B, 52-week range 1620-2259. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Shofu's full fundamentals live
Get Shofu's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.